Oasis Capital won "Digital Healthcare Investment Firm of the Year" at the 2023 Future Healthcare Top 100 Awards.

Recently, the 7th Future Healthcare 100 Conference, themed "East and West," kicked off in Shanghai, unveiling the 2023 Future Healthcare 100 list.

Founded in 2015, the Future Healthcare 100 list is China's first ranking focused on innovative healthcare companies that have not yet gone public, launched by VB100, VBData, and Eggshell Research Institute. Its mission is to identify Chinese innovators who truly represent the future of healthcare, discover the core forces driving the country's healthcare industry, and accelerate innovation and transformation in the health sector. Over seven years, the Future Healthcare 100 evaluation system has steadily expanded, gradually building a global innovation ecosystem that covers enterprises, investment institutions, and industrial parks, with extensions into product and technology innovation categories.

Among the awardees, Oasis Capital received the "Digital Healthcare Investor of the Year" honor.

In a world of constant change and overwhelming noise, Oasis Capital will continue to adhere to a "top-down" research approach, combining ecosystem entrepreneur experience to deliver clear signals to our portfolio companies over the long term. We remain focused on "demographic structure" and "technological innovation" as our entry points, investing in areas such as robotics, artificial intelligence, and technology services — backing the most vital entrepreneurs for the long haul. Celebrating Vitality.

Click "Read Original" to view the full list.

Oasis Capital is a new-generation venture capital firm in China, dedicated to discovering the most vital entrepreneurs of the coming decade and growing alongside them to create long-term value. "Celebrating Vitality" is Oasis's vision and mission. This vitality — Vitality — represents both the direction of structural transformation in our era and the resilience and evolutionary power of entrepreneurs.

Oasis Capital focuses on early and growth-stage investments, with individual check sizes ranging from $3 million to $30 million. The firm concentrates on robotics, artificial intelligence, technology services, and other fields, supporting the upgrade of China's technology-driven new services.